Stay updated with breaking news from Genentech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
![[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19 - Vimarsana News](https://www.marketscreener.com/images/twitter_MS_fdnoir.png)
Group sales grew by 2%1 at constant exchange rates , driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there...
The event will include a career fair, a movie night and several facility tours, all designed to give residents and job seekers a sense of what biotech is all about and what the field means to Vacaville.
Former Stanford president, Marc Tessier-Lavigne, is the CEO of new biopharma startup, Xaira. The startup already has $1 billion in investments and seeks to use AI to generate molecules to treat diseases.
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript April 23, 2024 Kiniksa Pharmaceuticals, Ltd. beats earnings expectations. Reported EPS is $-0.00025, expectations were $-0.14. KNSA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
Xaira's CEO, Dr. Marc Tessier-Lavigne, resigned as president of Stanford University last August due to controversy over inaccuracies discovered in his lab's scientific papers.